RE: AstraZeneca's COVID-19 vaccine candidate begins late-stage U.S. study1 Sep 2020 09:01
Agreed...
The focus has been off COVID for a little while as it's become a little repetitive and people are trying to move on but the impact of a successful vaccine means a reduction in current costs and an increase in confidence particularly in the service and leisure industry, albeit not immediately but overtime. Irrespective of the actual lag between vaccine roll-out the news is great!
It's just been reported on Bloomberg main headlines... etc